You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Volagidemab

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial (Sotagliflozin, Volagidemab)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Jan 20, 2023

Hyperglycemia Drug Induced Trial in Durham (REMD-477)

Terminated
  • Hyperglycemia Drug Induced
  • REMD-477
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

Hyperglycemia Drug Induced Trial in Durham (REMD-477)

Terminated
  • Hyperglycemia Drug Induced
  • REMD-477
  • Durham, North Carolina
    Duke University Medical Center
Jun 9, 2021

Type 1 Diabetes Trial in La Jolla (Dapagliflozin 10 MG [Farxiga], REMD-477, Placebo)

Completed
  • Type 1 Diabetes
  • Dapagliflozin 10 MG [Farxiga]
  • +2 more
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Jan 20, 2023

Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • San Antonio, Texas
    Texas Diabetes Institute
Dec 22, 2021

Type 1 Diabetes Trial in La Jolla (REMD-477, Placebo)

Recruiting
  • Type 1 Diabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Sep 22, 2021

Type1 Diabetes Trial in United States (REMD-477, Placebo Comparator)

Completed
  • Type1 Diabetes Mellitus
  • REMD-477
  • Placebo Comparator
  • Escondido, California
  • +10 more
Apr 2, 2021

Type 2 Diabetes, Diabetes Trial in Miami, San Antonio, Renton (REMD-477)

Completed
  • Type 2 Diabetes Mellitus
  • Diabetes
  • REMD-477
  • Miami, Florida
  • +2 more
Apr 9, 2018

Type 1 Diabetes, Diabetes Trial in San Diego, St. Louis (REMD-477, Placebo Comparator)

Completed
  • Type 1 Diabetes Mellitus
  • Diabetes
  • REMD-477
  • Placebo Comparator
  • San Diego, California
  • +1 more
Feb 6, 2017